Tradeshows, conferences, weddings, and gatherings of all kinds are finally able to “save the date” by utilizing our COVID-19 suite of testing solutions. We’ll provide PCR testing prior to the event, and Rapid Antigen testing (in addition to PCR testing) on the day of the event, to provide you and your guests with complete piece of mind – with everyone’s safety being paramount.
LabDX is leading the charge in helping to reopen the travel industry. Partnering with the airline industry, cruise lines, local government agencies, and tourism associations.
We’re incredibly proud of our part in ensuring that great organizations like the Turks & Caicos Hotel and Tourism Association can safely test their visitors using our COVID-19 testing solutions.
We’ve helped some of the first production teams (TV and Film) in the country to restart filming by adding our testing to their safety plans. If you’re looking to grab the gear and restart your production, we can help make that happen! Whether your team is all local, dispersed, or distributed – we’ll get you back to business.
Working with government and local agencies since the start of the pandemic, we’re here to provide on-demand Coronavirus testing to your staff, constituents, and your local residents.
Guests staying at your hotel or resort need to be sure they are bringing their family and co-workers to a COVID-free environment and that the hotel is being proactive about prevention.
With restaurants reopening at a reduced capacity, patrons need to be sure that food-handling employees are tested. Being in the food service industry also presents a unique challenge as patrons need to remove their masks in order to enjoy their meals. Being certain they are patronizing an establishment that is being proactive about prevention will help ensure a successful reopening and instill confidence in returning patrons.
Retail stores have been especially affected by the closures in the past year, and customers are willing to shop online to avoid contact with others. As stores reopen and invite customers back in, it’s important to demonstrate to your customers that you are being proactive in ensuring their safety.
As we continue to reopen the country, and vaccines start rolling out, ensuring the safety of customers and employees has become a priority. Customers want to make sure you are doing everything you can to protect them, and employees want to be in a safe environment - free of any risk of being exposed to the virus.
With over 25 million confirmed cases and over 443,000 deaths in the United States, being proactive about safety is paramount and will dictate the success of your business moving forward. Failing to be proactive about this new norm can be fatal to businesses attempting to reopen.
Our COVID-19 PCR Test is an RT-PCR test, which is a diagnostic test that can show if you have an active Coronavirus infection and whether or not you should take steps to quarantine or isolate yourself from others.
The RT-PCR test is currently the gold standard for SARS-CoV-2 (COVID-19) testing because of its high sensitivity and because it detects the virus’s genetic material.
Rapid Antigen testing for Coronavirus is offered in addition to our COVID-19 PCR testing in order to offer an additional blanket of detection, protection, and safety. This add-on test is for added piece of mind when testing for Coronavirus in the earliest stages of detection.
Our COVID-19 Antibody Testing is a Rapid Antibody test can help identify an immune response to SARS-CoV-2 (COVID-19), indicating a recent or prior infection. These antibodies are generally detectable in blood several days after initial infection. You may have detectable virus present for several weeks.
Rapid Antibody tests play a critical role by helping to identify who may have antibodies to the SARS-CoV-2 virus and have developed an adaptive immune response.
LabDX COVID-19 PCR test has not been authorized by the FDA under an Emergency Use Authorization (EUA) for qualitative detection of nucleic acid through real-time polymerase chain reaction (RT-PCR) from SARS-CoV-2 in upper respiratory samples during the acute phase of the infection of COVID- 19, not for any other viruses or pathogens. The test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
LabDX is providing testing based on tests from various manufacturers. Such tests have either received an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) or were released for use under FDA guidance. Tests being performed under an EUA have not been FDA cleared or approved and LabDX has completed independent validation of these tests. In addition, various manufacturers have submitted or will seek EUA for their tests.
The cash price for this test is $149. This is an in vitro diagnostic test for which the developer of the test has requested emergency use authorization from the US Food and Drug Administration (FDA) for diagnostic testing in CLIA Certified high-complexity laboratories.